当前位置:
新闻详情 

White Paper: Container Closure Integrity Control versus Integrity Testing during Routine Manufacturing

来源: | 作者:pmo90dc87 | 发布时间 :2024-12-10 | 144 次浏览: | 分享到:
1. Introduction

Container closure integrity (CCI) is the ability of acontainer closure system to maintain the sterility and product quality of sterile final pharmaceutical, biological, and vaccine products throughout their shelf-life. It is a regulatory requirement that the design of a container closure system b qualified. There are multiple methods available to qualify the effectiveness of a selected container closure system as detailed in industry guidance and literature. Selection of an appropriate method is based on the container closure system to be qualified and its contents. The norma variation within the manufacturing process should be taken into consideration when qualifying the integrity
of the closure system.

1. Introduction

Container closure integrity (CCI) is the ability of a

container closure system to maintain the sterility and

product quality of sterile final pharmaceutical, biological,

and vaccine products throughout their shelf-life.

It is a regulatory requirement that the design of a

container closure system be qualified. There are multiple

methods available to qualify the effectiveness of

a selected container closure system as detailed in

industry guidance and literature. Selection of an appropriate

method is based on the container closure

system to be qualified and its contents. The normal

variation within the manufacturing process should be

taken into consideration when qualifying the integrity

of the closure system.

While the regulatory expectations and industry standard

practices for initial CCI qualification are well

defined, the regulatory requirements with respect to

in-process or routine manufacturing remain unclear

with the exception of fused containers.